debrisoquin has been researched along with Acroosteolysis, Giaccai Type in 1 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belec, L | 1 |
| Larrey, D | 1 |
| De Cremoux, H | 1 |
| Tinel, M | 1 |
| Louarn, F | 1 |
| Pessayre, D | 1 |
| Gherardi, R | 1 |
1 other study available for debrisoquin and Acroosteolysis, Giaccai Type
| Article | Year |
|---|---|
Extensive oxidative metabolism of dextromethorphan in patients with almitrine neuropathy.
Topics: Aged; Almitrine; Debrisoquin; Dextromethorphan; Female; Hereditary Sensory and Autonomic Neuropathie | 1989 |